Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Amarin Corporation Plc (AMRN)
NASDAQ:AMRN
Amarin (AMRN) Stock Price & Analysis
3,140 Followers
AMRN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.65 - $1.49
Previous Close$0.92
Volume3.58M
Average Volume (3M)1.49M
Market Cap
$376.49M
Enterprise Value$64.52M
Total Cash (Recent Filing)$320.70M
Total Debt (Recent Filing)$8.74M
Price to Earnings (P/E)-6.3
Beta1.81
Next Earnings
Jul 31, 2024EPS Estimate
-$0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.14
Shares Outstanding410,671,800
10 Day Avg. Volume807,057
30 Day Avg. Volume1,486,801
Standard Deviation0.24
R-Squared0.20
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)0.68
Price to Sales (P/S)4.95
Price to Cash Flow (P/CF)-139.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.23
Enterprise Value/Gross Profit0.32
Enterprise Value/Ebitda-1.19
Forecast
1Y Price Target
$1.13Price Target Upside34.64% Upside
Rating ConsensusModerate Sell
Number of Analyst Covering2
Amarin News
PremiumCompany Announcements
Amarin Shareholders Show Strong Support at Annual Meeting
Bulls Say, Bears Say
Bulls Say
Financial HealthAmarin Corp. ended the year with a strong balance sheet, citing positive cash flow and substantial cash reserves.
Financial Performance4Q23 product revenue of $70.6mn came in above the analyst's consensus data.
Market ExpansionThe company is making strides in international markets, with efforts to secure reimbursement in key European countries.
Bears Say
Market CompetitionIncreasing competition from generic products continues to erode US sales, threatening the company's future revenue streams.
Profitability ConcernsA notable decline in gross margin, dropping significantly from previous levels, indicating potential long-term profitability issues.
Revenue DeclineThe introduction of icosapent ethyl generics is leading to significant price pressures, resulting in a substantial decline in revenue per prescription.
---
Ownership Overview
19.73% Insiders
0.75% Mutual Funds
0.71% Other Institutional Investors
78.81% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
AMRN FAQ
What was Amarin Corporation Plc’s price range in the past 12 months?
Amarin Corporation Plc lowest stock price was $0.65 and its highest was $1.49 in the past 12 months.
What is Amarin Corporation Plc’s market cap?
Currently, no data Available
When is Amarin Corporation Plc’s upcoming earnings report date?
Amarin Corporation Plc’s upcoming earnings report date is Jul 31, 2024 which is in 90 days.
How were Amarin Corporation Plc’s earnings last quarter?
Amarin Corporation Plc released its earnings results on May 01, 2024. The company reported -$0.02 earnings per share for the quarter, beating the consensus estimate of -$0.03 by $0.01.
Is Amarin Corporation Plc overvalued?
According to Wall Street analysts Amarin Corporation Plc’s price is currently Undervalued.
Does Amarin Corporation Plc pay dividends?
Amarin Corporation Plc does not currently pay dividends.
What is Amarin Corporation Plc’s EPS estimate?
Amarin Corporation Plc’s EPS estimate is -$0.04.
How many shares outstanding does Amarin Corporation Plc have?
Amarin Corporation Plc has 410,671,800 shares outstanding.
What happened to Amarin Corporation Plc’s price movement after its last earnings report?
Amarin Corporation Plc reported an EPS of -$0.02 in its last earnings report, beating expectations of -$0.03. Following the earnings report the stock price went down -8.696%.
Which hedge fund is a major shareholder of Amarin Corporation Plc?
Among the largest hedge funds holding Amarin Corporation Plc’s share is SCP Investment, LP. It holds Amarin Corporation Plc’s shares valued at 2M.
---
Amarin Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Sell
Average Price Target:
$1.13 (34.64% Upside)
$1.13 (34.64% Upside)
Blogger Sentiment
Neutral
AMRN Sentiment 50%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 2.3M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days <0.1%
Last 30 Days ▼ 0.9%
Last 30 Days ▼ 0.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-31.85%
12-Months-Change
Fundamentals
Return on Equity
-10.33%
Trailing 12-Months
Asset Growth
-6.15%
Trailing 12-Months
Company Description
Amarin Corporation Plc
Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. Its product development program leverages its experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. It has developed and markets Vascepa capsules through wholesale. The company was founded by Geoffrey W. Guy on March 1, 1989 and is headquartered in Dublin, Ireland.
---
AMRN Earnings Call
Q1 2024
0:00 / 0:00
---
AMRN Stock 12 Months Forecast
Average Price Target
$1.13
▲(34.64% Upside)
Technical Analysis
Best Analysts Covering AMRN
1 Year
1 Year Success Rate
6/31 ratings generated profit
1 Year Average Return
-8.11%
reiterated a buy rating 10 months ago
Copying Louise Chen's trades and holding each position for 1 Year would result in 19.35% of your transactions generating a profit, with an average return of -8.11% per trade.
---